[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359637-105":59,"doc-detail-359637-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","uridine-metabolism-promotes-lung-adenocarcinoma-progression-by-activating-fbl-transcription-via-ybx1","Uridine metabolism promotes lung adenocarcinoma progression by activating FBL transcription via YBX1","","Uridine metabolism functions as a compensatory metabolic pathway in tumor cells experiencing glucose deprivation, yet its causal mechanism in cancer progression remains unclear. This study integrates pan-cancer TCGA profiling and single-cell RNA sequencing of the tumor microenvironment, supported by enrichment and transcription-factor network analyses that nominate YBX1 as a key downstream regulator. Multi-modal validation shows uridine metabolism promotes ribosome biogenesis through YBX1 lactylation, YBX1-driven FBL promoter activation, and inhibition of malignant phenotypes by YBX1/FBL silencing, with in vivo tumor growth suppression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/uridine-metabolism-promotes-lung-adenocarcinoma-progression-by-activating-fbl-transcription-via-ybx1/359637/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/uridine-metabolism-promotes-lung-adenocarcinoma-progression-by-activating-fbl-transcription-via-ybx1/359637.png","ImageObject",300,407,{"name":92,"@type":93},"Maya Linwood","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What key mechanism links uridine metabolism to lung adenocarcinoma progression?","Question",{"text":112,"@type":113},"The study identifies a uridine metabolism–YBX1–FBL axis. Uridine metabolism promotes ribosome biogenesis by stabilizing YBX1 and enabling YBX1 binding to the FBL promoter to activate FBL transcription.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers determine YBX1 as a downstream regulator?",{"text":117,"@type":113},"They analyzed distinct uridine metabolism patterns across cancer types using TCGA pan-cancer data and used enrichment and transcription factor network mapping. YBX1 emerged as a key downstream transcriptional regulator for the identified uridine-related program.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports the functional role of YBX1 and FBL?",{"text":121,"@type":113},"Silencing YBX1 or FBL inhibited tumor cell proliferation, migration, and stemness in functional assays. In vivo, knockdown of YBX1 or FBL significantly reduced tumor growth, and rescue experiments supported causality for YBX1/FBL-driven oncogenic phenotypes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359637,1790619513,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Wang et al. Journal of Translational Medicine (2026) 24:518  \n[https://doi.org/10.1186/s12967-026-08034-z](https://doi.org/10.1186/s12967-026-08034-z)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nUridine metabolism promotes lung adenocarcinoma progression by activating FBL transcription via YBX1  \nXinyi Wang1†, Liang Chen1†, Yingge Li1, Luojun Chen1, Chunmei Hao1, Qilu Yan1, Shuyang Yu1, Cai Zhang1, Ruibin Li 1, Bin Xu1*, Yi Yao1* and Qibin Song1*  \nAbstract  \nBackground Uridine metabolism serves as a critical compensatory metabolic pathway in tumor cells under glucose deprivation. However, the mechanistic role of uridine metabolism in tumorigenesis and progression has not been elucidated.  \nMethod Distinct uridine metabolism patterns across pan-cancer types were analyzed using theTCGA database. Single-cell RNA sequencing was used to delineate uridine metabolic variations within the tumor microenvironment (TME) . Through comprehensive bioinformatics analyses, including enrichment and transcription factor network mapping, YBX1 was identified as a key downstream transcriptional regulator. RNA sequencing, chromatin immunoprecipitation quantitative PCR (ChIP-qPCR), and immunoprecipitation (IP) assays were used to explored the key regulatory targets ofthe transcription factor. Furthermore, the role ofYBX1 in promoting tumor progression via ribosome biogenesis was further investigated.  \nResult Pan-cancer analyses demonstrated a strong correlation between elevated uridine metabolism levels and unfavorable clinical outcomes, particularly in lung adenocarcinoma (LUAD) . Single-cell analysis revealed that uridine metabolism promoted ribosomal biogenesis and identified YBX1 as the key transcription factor responsible for  \nthis regulation. Mechanistically, we found that uridine metabolism led to YBX1 lactylation at the K137 site, thereby stabilizing theYBX1 protein. By integrating RNA-sequencing and ChIP-qPCR assays, we found that YBX1 transactivated FBL expression by directly binding to its promoter, thereby modulating ribosome biogenesis. Functional assays demonstrated that silencing either YBX1 or FBL inhibited tumor cell proliferation, migration, and stemness. In vivo, we validated that knockdown of YBX1 or FBL significantly reduced tumor growth in mice. Moreover, our rescue  \n†Xinyi Wang and Liang Chen contributed equally to this work and share first authorship.  \n*Correspondence:  \nBin Xu [xubin_oncology@whu.edu.cn](xubin_oncology@whu.edu.cn)[ ](xubin_oncology@whu.edu.cn)Yi Yao  \n[yaoyi2018@whu.edu.cn](yaoyi2018@whu.edu.cn)[ ](yaoyi2018@whu.edu.cn)Qibin Song [qibinsong@whu.edu.cn](qibinsong@whu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nWang et al. Journal of Translational Medicine (2026) 24:518 Page 2 of 19  \nexperiments provided causal evidence that ","cbCaiioYhtQCfrek","https://ap.wps.com/l/cbCaiioYhtQCfrek","pdf",10429571,"English","# Abstract\n## Background\n## Method\n## Result\n## Conclusion\n# Introduction\n## Lung cancer epidemiology and therapeutic gaps\n## Biological roles of uridine","[{\"question\":\"What key mechanism links uridine metabolism to lung adenocarcinoma progression?\",\"answer\":\"The study identifies a uridine metabolism–YBX1–FBL axis. Uridine metabolism promotes ribosome biogenesis by stabilizing YBX1 and enabling YBX1 binding to the FBL promoter to activate FBL transcription.\"},{\"question\":\"How did the researchers determine YBX1 as a downstream regulator?\",\"answer\":\"They analyzed distinct uridine metabolism patterns across cancer types using TCGA pan-cancer data and used enrichment and transcription factor network mapping. YBX1 emerged as a key downstream transcriptional regulator for the identified uridine-related program.\"},{\"question\":\"What experimental evidence supports the functional role of YBX1 and FBL?\",\"answer\":\"Silencing YBX1 or FBL inhibited tumor cell proliferation, migration, and stemness in functional assays. In vivo, knockdown of YBX1 or FBL significantly reduced tumor growth, and rescue experiments supported causality for YBX1/FBL-driven oncogenic phenotypes.\"}]","Uridine metabolism promotes lung adenocarcinoma progression by activating FBL transcription via YBX1 | PDF",1790137354,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3dffcd9176a90578c1e383c15e130c9e.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c120cc42cec01942ae128335b7dfb52c.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ddbdce187a176fb6622a9de01655ebef.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29c8d142c251689cc2c67bc51bd21bfd.webp",980,1306]